Choosing what to run

Pick one goal, not five

Almost everyone arrives with a list: lose fat, sleep better, fix a shoulder, think more clearly. All of them are legitimate. Pursuing them at once is the single most common way people waste a year.

Rank them and let the top one drive the decision. Secondary goals get their turn once the first intervention is established and you know what it is doing. Run sequentially and each change has a visible cause; run in parallel and you get a fog of overlapping effects you cannot attribute to anything.

Decide what "working" means before you start

Write the measure down first, while you are still capable of being honest about it. Retrospective judgement is unreliable in exactly the direction you would expect: people who have spent money on something tend to find it worked.

Pick something you can actually record — weight and waist, a lift at a fixed load, resting heart rate, hours of deep sleep, a pain score on a specific movement, sessions completed per week. Subjective measures are fine if you log them daily rather than reconstructing them at the end.

Then set the timeline honestly, because it varies enormously by goal:

"First signal" is when a real effect would begin to be noticeable. "Fair verdict" is the earliest point at which concluding it did not work is reasonable. Both are informed estimates from typical trial durations, not guarantees.

Matching a goal to a category

What follows maps goals onto the categories covered in the foundations primer, with the grade this site applies to that specific use — not to the compound in general. A compound can be Grade A for one indication and Grade D for another, and most disappointment comes from buying the A and expecting the D.

Read that table for the pattern rather than the rows. The two goals with Grade A answers are fat loss and metabolic health. Everything else is C or D — plausible, sometimes promising, not established. If your goal sits in the lower half, the honest framing is that you are running an experiment, and it should be budgeted and expected accordingly.

What your own situation changes

• Age. Secretagogues have more room to work where output has actually declined. Under thirty there is usually less headroom, and the case for them is weaker.
• Existing conditions. Diabetes, cardiovascular disease, thyroid disorders, and any history of cancer change the risk calculation entirely and rule some options out. This is the part that needs a clinician rather than a forum.
• Current medications. Interactions are real, and GLP-1 agonists slow gastric emptying, which affects how other oral drugs are absorbed. Review the whole list, not just the obvious ones.
• Training status. If you are not training, recovery and performance compounds have nothing to recover from. Metabolic goals are the only ones that make sense from a standing start.
• Previous response. How you responded to related interventions is genuinely informative. Someone who responded well to hormone therapy is a more plausible responder to secretagogues.

Running a trial on yourself

Once you have one goal, one measure, and one candidate, the mechanics matter more than the choice does.

• One variable at a time. Not just one compound — do not start a new training block or diet in the same fortnight. Otherwise you are back to the attribution problem.
• Start low. Conservative dosing tells you where your own sensitivity and side effects sit before you commit to a full protocol, and it costs you nothing but time.
• Baseline first. Two weeks of the measure before you start anything. Without it you are comparing against memory.
• Set a stop rule in advance. Decide now what result, or what side effect, ends the trial. Deciding in the moment is how people continue paying for things that are not working.
• Get clinical oversight if you have any condition, take any medication, or plan to run anything for more than a few months. Bloodwork before and during is the only way some risks are visible at all.

Adding to something you already run

If you are already on hormone therapy or another intervention, the same logic applies with more force. Secretagogues and testosterone therapy are often run together and are not obviously in conflict, but every addition makes attribution harder and monitoring more complicated.

• Introduce one thing at a time, with enough of a gap to tell what did what.
• Timing is a real variable. Some compounds are affected by food or by proximity to training; get the schedule right before concluding something does not work.
• Spend on the biggest lever. Very few people need several at once. The money usually goes further on one thing done properly and for long enough.
• Prefer what you can sustain. Most of these require ongoing use to hold their effect. A protocol you can afford for two years beats one you abandon after eight weeks.

Sourcing and quality

Outside the approved prescription drugs, most of what is discussed here is sold as a research chemical, labelled not for human consumption. That label is the seller's legal position rather than a description of what buyers do, and it is worth being clear-eyed that the gap is the entire market. It also means no regulator is checking what is in the vial.

So the supplier is not a detail, it is most of the risk. What to demand:

• A certificate of analysis for the batch you are buying — not a generic one for the product line, and ideally from an independent lab rather than in-house.
• Purity and identity testing, typically HPLC and mass spectrometry, showing the vial contains what the label says in the amount claimed.
• Sterility and endotoxin results, which matter more than purity for anything injected and are the test most often quietly missing.
• Storage that matches the compound. Most need refrigeration, many degrade once reconstituted, and a supplier who is vague about handling is telling you something.

Nalu Labs is one such supplier, and is where this site's links point. Disclosure: that is a commercial link and Protocol Index has a financial relationship with them — see independence and funding. Hold them to the same list above; a supplier worth using will not mind being asked.

What to expect, honestly

• Moderate, not transformative. The realistic outcome across most of this space is an improvement you can measure but would not necessarily notice without measuring.
• Response varies a lot. Age, genetics, baseline health, and how well the fundamentals are already handled all move the result. Someone else's outcome is weak evidence about yours.
• Benefits are rented, not owned. Most effects fade when use stops. That is a recurring cost, and it should be in the decision from the start.
• The floor is still the floor. Sleep, food, training, and stress set the ceiling on what any of this can add. Peptides move a well-run system further; they do not rescue a badly run one.

Before you act on any of this

Read the foundations primer